Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 276.00
Bid: 271.00
Ask: 276.00
Change: -1.00 (-0.36%)
Spread: 5.00 (1.845%)
Open: 277.00
High: 280.00
Low: 274.00
Prev. Close: 277.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: CVS Group CEO Halves Stake

Fri, 10th Apr 2015 13:02

Director Dealings Summary - Week Ended April 10        
Company Name Position Number of Shares Resulting Holding *Note GBP Value
             
             
BUYS            
             
Hutchison China MediTech  Simon To Chairman 58,000 127,000   800,000
Strategic Minerals John Peters Chairman 1 million 1 million First purchase. 600,000
Hutchison China MediTech  Edith Shih Non-Executive Director 12,000 60,000   166,000
Hydrodec Andrew Black Non-Executive Director 1,750,000 183.6 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 121,000
Dunedin Enterprise Investment Trust Duncan Budge Chairman 20,000 35,900 Week after making GBP5 million investment in Blackrock Programme Management. 68,000
Amerisur Resources John Wardle CEO 248,000 17.6 million Purchased by Tracarta in which Wardle has a beneficial interest. 60,000
Amerisur Resources Douglas Ellenor Non-Executive Director 200,000 1.2 million Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. 50,000
Chime Communications Mervyn Davies Chairman 17,936 67,785   50,000
Synety Graham Ward Non-Executive Director 28,075 234,870 2 days after share placing and open offer. 25,000
JPMorgan Brazil Investment Trust Victor Bulmer-Thomas Non-Executive Director 43,750 159,850   24,000
Hydrodec Colin Moynihan Chairman 310,155 10.2 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 20,000
Xaar Edmund Creutzmann CTO 4,846 4,846 First purchase. 20,000
Dunedin Enterprise Investment Trust Federico Marescott Director 6,000 10,000 Week after making GBP5 million investment in Blackrock Programme Management. 20,000
Synectics Peter Rae Non-Executive Director 14,000 232,302   18,000
Michelmersh Frank Hanna Commercial Director 21,985 1.3 million 2 weeks after reinstating its dividend payout. 15,000
Hydrodec Ian Smale CEO 200,000 1.1 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 14,000
Amerisur Resources Nick Harrison CFO 50,000 5.7 million Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. 12,000
Standard Life Elizabeth Noel Harwerth Non-Executive Director 1,893 10,074   8,900
Concurrent Technologies David Evans-Hughes Engineering Director 8,755 948,206   3,900
             
             
SELLS            
             
Amec Foster Wheeler Kent Masters Non-Executive Director 347,273 70,000 (in the form of ADRs) Week after winning EDF Energy UK nuclear power station deal. 3,800,000
CVS Group Simon Innes CEO 300,000 246,475 Sold more than half his stake. 1,700,000
Domino Printing Sciences  Peter Byrom Chairman 11,932  338,000   111,000
             
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director.
 
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam      
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
23 Jun 2021 18:10

IN BRIEF: Hutchmed launches global offering for 104 million shares

IN BRIEF: Hutchmed launches global offering for 104 million shares

Read more
22 Jun 2021 20:16

IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China

IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China

Read more
18 Jun 2021 17:26

IN BRIEF: Hutchmed launches Hong Kong IPO; drug candidate approved

IN BRIEF: Hutchmed launches Hong Kong IPO; drug candidate approved

Read more
18 Jun 2021 08:52

Hutchmed China launches Hong Kong public offering

(Sharecast News) - Hutchmed China announced the launch of its Hong Kong public offering on Friday, as part of its global offering of 104 million new shares, proposing the primary listing of its ordinary shares on the main board of the Hong Kong Stock Exchange under the stock code '13'.

Read more
4 May 2021 20:25

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

Read more
29 Apr 2021 14:34

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Read more
21 Apr 2021 16:02

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
8 Apr 2021 15:57

IN BRIEF: Hutchison China gets USD100 million investment from Baring

IN BRIEF: Hutchison China gets USD100 million investment from Baring

Read more
29 Mar 2021 20:20

IN BRIEF: Hutchison China starts first phase trials for HMPL-306

IN BRIEF: Hutchison China starts first phase trials for HMPL-306

Read more
24 Mar 2021 16:44

TRADING UPDATES: Arden Partners to return to annual profitability

TRADING UPDATES: Arden Partners to return to annual profitability

Read more
4 Mar 2021 12:46

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

Read more
25 Feb 2021 16:19

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jan 2021 14:51

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

Read more
30 Dec 2020 22:05

IN BRIEF: Hutchison China Lands "Milestone" China Drug Green Light

IN BRIEF: Hutchison China Lands "Milestone" China Drug Green Light

Read more
29 Dec 2020 12:31

Hutchison China Files US FDA Drug Application For Cancer Treatment

Hutchison China Files US FDA Drug Application For Cancer Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.